Literature DB >> 20662839

Should ustekinumab really be used as first-line biological therapy in pityriasis rubra pilaris?

R Balestri, F Bardazzi, A Antonucci.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20662839     DOI: 10.1111/j.1365-2133.2010.09942.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


× No keyword cloud information.
  2 in total

Review 1.  Management of refractory pityriasis rubra pilaris: challenges and solutions.

Authors:  Gaia Moretta; Erika V De Luca; Alessandro Di Stefani
Journal:  Clin Cosmet Investig Dermatol       Date:  2017-11-09

2.  Emerging dermatological and systemic applications of ustekinumab: beyond its clinical use in psoriasis.

Authors:  Shailendra Kapoor
Journal:  Clin Cosmet Investig Dermatol       Date:  2012-06-21
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.